CAMBRIDGE, Mass., Aug. 25, 2022 -- Aktis Oncology, a biotechnology company discovering and developing novel classes of targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today announced...
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
Venture Partner Mike Grey named EY Entrepreneur Of The Year San Diego
